Enhanced Expression of Interleukin-8 and Activation of Nuclear Factor Kappa-B in Endoscopy-negative Gastroesophageal Reflux Disease

American Journal of Gastroenterology

Volumn 99, Issue 4, 2004, Pages 589-597

  Isomoto, Hajime ^a   Saenko, Vladimir A ^b   Kanazawa, Yusei ^b   Nishi, Yoshito ^b   Ohtsuru, Akira ^b   Inoue, Kenichiro ^b   Akazawa, Yuko ^b   Takeshima, Fuminao ^b   Omagari, Katsuhisa ^b   Miyazaki, Masanobu ^b   Mizuta, Yohei ^b   Murata, Ikuo ^b   Yamashita, Shunichi ^b   Kohno, Shigeru ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; FORMALDEHYDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; LANSOPRAZOLE; MESSENGER RNA; PROTEIN P50; PROTEIN SUBUNIT; SYNAPTOTAGMIN;

ADULT; AGED; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; ENDOSCOPY; ENZYME ACTIVATION; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; FROZEN SECTION; GASTROESOPHAGEAL REFLUX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LOWER ESOPHAGUS SPHINCTER; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REFLUX ESOPHAGITIS; SYMPTOM; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGOSCOPY; ESOPHAGUS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; MIDDLE AGED; MUCOUS MEMBRANE; NF-KAPPA B; RNA, MESSENGER;

EID: 2342658952     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.04110.x     Document Type: Article

References (33)

1. Kobayashi S, Kasugai T. Endoscopic and biopsy criteria for the diagnosis of esophagitis with a fibreoptic esophagoscope. Dig Dis 1974;19:345-52.
2. Frierson HF Jr. Histology in the diagnosis of reflux esophagitis. Gastroenterol Clin North Am 1990;19:631-44.
3. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of esophagitis: Clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:631-44.
4. Heading R. Epidermiology of oesophageal reflux disease. Scand J Gastroenterol 1989;24:25-36.
5. Winters C, Spurling T, Chobanian S, et al. Barrett's esophagus: A prevalent occult complication of gastro-esophageal reflux disease. Gastroenterology 1987;92:118-24.
6. Spechler SJ, Zeroogian JM, Antonioli DA, et al. Prevalence of metaplasia at the gastro-esophageal junction. Lancet 1994;344:1533-6.
7. Cameron A, Kamath P, Carpenter H. Prevalence of Barrett's esophagus and intestinal metaplasia at the esophagogastric junction. Gastroenterology 1997;112:A82.
8. Hirschowitz B. Gastric acid and pepsin secretion in patients with Barrett's esophagitis and appropriate controls. Dig Dis Sci 1996;41:1384-91.
9. Liron R, Parrilla P, Martinez de Haro LF, et al. Quantification of duodenogastric reflux in Barrett's esophagus. Am J Gastroenterol 1997;92:32-6.
10. Avidan B, Sonnenberg A, Schnell T. Acid reflux is a poor predictor of esophageal mucosal injury. Gastroenterology 2000;118:A2584.
11. Lanas A, Royo Y, Orte GOJ, et al. Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis. Gastroenterology 1999;116:97-107.
12. Fitzgerald RC, Onwuegbusi BA, Bajaj-Elliott M, et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: Immunological determinants. Gut 2002;50:451-9.
13. Isomoto H, Wang A, Mizuta Y, et al. Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol 2003;98:551-6.
14. Fitzgerald RC, Abdalla S, Onwuegbusi BA, et al. Inflammatory gradient in Barrett's oesophagus: Implications for disease complications. Gut 2002;51:316-22.
15. Epstein FH. Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-71.
16. Baeuerle PA, Baltimore D. NF-κB: Ten years after. Cell 1996;87:13-20.
17. Isomoto H, Mizuta Y, Miyazaki M, et al. Implication of NF-κB in Helicobacter pylori-associated gastritis. Am J Gastroenterol 2000;95:2768-76.
18. Oh TY, Lee JS, Ahn BO, et al. Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut 2001;49:364-71.
19. Mukaida N. Interleukin-8: An expanding universe beyond neutrophil chemotaxis and activation. Int J Hematol 2000;72:391-8.
20. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-9.
21. Jones MP, Sloan SS, Rabine JC, et al. Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease. Am J Gastroenterol 2001;96:1711-7.
22. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-74.
23. Yuan A, Yang PC, Yu CJ, et al. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med 2000;162:1957-63.
24. Rogounovitch TI, Saenko VA, Shimizu-Yoshida Y, et al. Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res 2002;62:7031-41.
25. Kondo S, Yoneta A, Yazawa H, et al. Down regulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UVB. J Cell Physiol 2000;182:366-70.
26. Ohnita K, Isomoto H, Mizuta Y, et al. Helicobacterpylori infection in patients with gastric involvement by adult T-cell leukemia/lymphoma. Cancer 2002;94:1507-16.
27. Renard P, Ernest I, Houbion A, et al. Development of a sensitive multi-well colorimetric assay for active NFκB. Nucleic Acids Res 2001;29:e21.
28. Portis T, Harding JC, Ratner L. The contribution of NF-κB activity to spontaneous proliferation and resistance to apoptosis in human T-cell leukemia virus type 1 Tax-induced tumors. Blood 2001;98:1200-8.
29. Isomoto H, Furusu H, Morikawa T, et al. 5-day vs. 7-day triple therapy with rabeprazole, clarithromycin and amoxicillin for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000;14:1619-23.
30. Chuntharapai A, Kim KJ. Regulation of the expression of IL-8 receptor A/ B by IL-8: Possible functions of each receptor. J Immunol 1995;155:2587-94.
31. Metzner B, Hofmann C, Heinemann C, et al. Overexpression of CXC-chemokines and CXC-chemokine receptor type 2 constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431. Oncol Rep 1999;6:1405-10.
32. Zachrisson K, Neopikhanov V, Samali A, et al. Interleukin-1, interleukin-8, tumour necrosis factor alpha and interferon gamma stimulate DNA synthesis but have no effect on apoptosis in small intestinal cell lines. Eur J Gastroenterol Hepatol 2001;13:551-9.
33. Sfakianakis A, Barr CE, Kreutzer DL. Localization of the chemokine interleukin-8 receptors in human gingival and cultured gingival keratinocytes. J Pediodont Res 2002;87:154-60.